|
Gene: PINX1 |
Gene summary for PINX1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | PINX1 | Gene ID | 54984 |
Gene name | PIN2 (TERF1) interacting telomerase inhibitor 1 | |
Gene Alias | Gno1 | |
Cytomap | 8p23.1 | |
Gene Type | protein-coding | GO ID | GO:0000070 | UniProtAcc | Q96BK5 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
54984 | PINX1 | LZE4T | Human | Esophagus | ESCC | 5.64e-03 | 7.86e-02 | 0.0811 |
54984 | PINX1 | LZE24T | Human | Esophagus | ESCC | 7.17e-09 | 5.97e-02 | 0.0596 |
54984 | PINX1 | P2T-E | Human | Esophagus | ESCC | 3.59e-18 | 4.14e-01 | 0.1177 |
54984 | PINX1 | P4T-E | Human | Esophagus | ESCC | 8.22e-06 | 1.84e-02 | 0.1323 |
54984 | PINX1 | P5T-E | Human | Esophagus | ESCC | 6.43e-13 | 5.83e-02 | 0.1327 |
54984 | PINX1 | P8T-E | Human | Esophagus | ESCC | 1.60e-02 | -1.63e-02 | 0.0889 |
54984 | PINX1 | P9T-E | Human | Esophagus | ESCC | 8.31e-05 | 3.14e-02 | 0.1131 |
54984 | PINX1 | P10T-E | Human | Esophagus | ESCC | 1.08e-17 | 1.71e-01 | 0.116 |
54984 | PINX1 | P12T-E | Human | Esophagus | ESCC | 8.03e-13 | 1.09e-01 | 0.1122 |
54984 | PINX1 | P15T-E | Human | Esophagus | ESCC | 1.08e-05 | -2.30e-02 | 0.1149 |
54984 | PINX1 | P16T-E | Human | Esophagus | ESCC | 5.72e-17 | 1.52e-01 | 0.1153 |
54984 | PINX1 | P20T-E | Human | Esophagus | ESCC | 2.11e-08 | 2.59e-01 | 0.1124 |
54984 | PINX1 | P21T-E | Human | Esophagus | ESCC | 4.04e-17 | 1.77e-01 | 0.1617 |
54984 | PINX1 | P22T-E | Human | Esophagus | ESCC | 9.09e-10 | 1.14e-01 | 0.1236 |
54984 | PINX1 | P23T-E | Human | Esophagus | ESCC | 8.81e-14 | 2.00e-01 | 0.108 |
54984 | PINX1 | P24T-E | Human | Esophagus | ESCC | 2.81e-06 | 2.31e-01 | 0.1287 |
54984 | PINX1 | P26T-E | Human | Esophagus | ESCC | 1.17e-12 | 5.69e-02 | 0.1276 |
54984 | PINX1 | P27T-E | Human | Esophagus | ESCC | 2.15e-12 | 9.82e-02 | 0.1055 |
54984 | PINX1 | P28T-E | Human | Esophagus | ESCC | 2.49e-18 | 2.70e-01 | 0.1149 |
54984 | PINX1 | P30T-E | Human | Esophagus | ESCC | 7.90e-08 | 2.27e-01 | 0.137 |
Page: 1 2 3 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:190382927 | Skin | AK | positive regulation of cellular protein localization | 64/1910 | 276/18723 | 2.23e-10 | 3.00e-08 | 64 |
GO:003139728 | Skin | AK | negative regulation of protein ubiquitination | 30/1910 | 83/18723 | 2.29e-10 | 3.01e-08 | 30 |
GO:190332128 | Skin | AK | negative regulation of protein modification by small protein conjugation or removal | 32/1910 | 95/18723 | 4.71e-10 | 5.26e-08 | 32 |
GO:004477210 | Skin | AK | mitotic cell cycle phase transition | 83/1910 | 424/18723 | 3.81e-09 | 3.05e-07 | 83 |
GO:005109826 | Skin | AK | regulation of binding | 74/1910 | 363/18723 | 4.40e-09 | 3.30e-07 | 74 |
GO:003164728 | Skin | AK | regulation of protein stability | 64/1910 | 298/18723 | 5.93e-09 | 4.14e-07 | 64 |
GO:000734616 | Skin | AK | regulation of mitotic cell cycle | 87/1910 | 457/18723 | 6.50e-09 | 4.47e-07 | 87 |
GO:005109926 | Skin | AK | positive regulation of binding | 42/1910 | 173/18723 | 6.92e-08 | 3.38e-06 | 42 |
GO:003450419 | Skin | AK | protein localization to nucleus | 60/1910 | 290/18723 | 7.27e-08 | 3.53e-06 | 60 |
GO:001063924 | Skin | AK | negative regulation of organelle organization | 64/1910 | 348/18723 | 2.19e-06 | 6.25e-05 | 64 |
GO:19019907 | Skin | AK | regulation of mitotic cell cycle phase transition | 57/1910 | 299/18723 | 2.47e-06 | 6.76e-05 | 57 |
GO:005165618 | Skin | AK | establishment of organelle localization | 69/1910 | 390/18723 | 3.69e-06 | 9.11e-05 | 69 |
GO:19019877 | Skin | AK | regulation of cell cycle phase transition | 69/1910 | 390/18723 | 3.69e-06 | 9.11e-05 | 69 |
GO:003304410 | Skin | AK | regulation of chromosome organization | 40/1910 | 187/18723 | 4.47e-06 | 1.07e-04 | 40 |
GO:000072320 | Skin | AK | telomere maintenance | 31/1910 | 131/18723 | 6.10e-06 | 1.39e-04 | 31 |
GO:003220418 | Skin | AK | regulation of telomere maintenance | 22/1910 | 80/18723 | 1.08e-05 | 2.28e-04 | 22 |
GO:190018019 | Skin | AK | regulation of protein localization to nucleus | 31/1910 | 136/18723 | 1.37e-05 | 2.70e-04 | 31 |
GO:005110126 | Skin | AK | regulation of DNA binding | 28/1910 | 118/18723 | 1.60e-05 | 3.09e-04 | 28 |
GO:00070594 | Skin | AK | chromosome segregation | 60/1910 | 346/18723 | 2.88e-05 | 4.98e-04 | 60 |
GO:190018218 | Skin | AK | positive regulation of protein localization to nucleus | 22/1910 | 87/18723 | 4.49e-05 | 7.06e-04 | 22 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PINX1 | SNV | Missense_Mutation | novel | c.581N>G | p.Gln194Arg | p.Q194R | Q96BK5 | protein_coding | tolerated(0.06) | benign(0.092) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PINX1 | SNV | Missense_Mutation | c.857N>A | p.Gly286Asp | p.G286D | Q96BK5 | protein_coding | tolerated(1) | benign(0) | TCGA-BH-A1EY-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
PINX1 | insertion | Nonsense_Mutation | novel | c.561_562insTCACCTAATACTGATTTATCTGTCACATGGCTGTAAATAGTGAC | p.Ala188SerfsTer12 | p.A188Sfs*12 | Q96BK5 | protein_coding | TCGA-A2-A04Y-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | ||
PINX1 | insertion | Nonsense_Mutation | novel | c.737_738insATCATTACAAATACATGCATTCATGTAAGTGTGCACAC | p.Glu247SerfsTer9 | p.E247Sfs*9 | Q96BK5 | protein_coding | TCGA-A8-A07J-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR | ||
PINX1 | insertion | Frame_Shift_Ins | novel | c.441dupT | p.Gly148TrpfsTer6 | p.G148Wfs*6 | Q96BK5 | protein_coding | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
PINX1 | insertion | Frame_Shift_Ins | novel | c.541_542insGTGCGCATCTGTGTGTGTGTGTGTGTGTCACTATCTCC | p.Tyr181CysfsTer22 | p.Y181Cfs*22 | Q96BK5 | protein_coding | TCGA-B6-A0IA-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
PINX1 | SNV | Missense_Mutation | c.538G>A | p.Glu180Lys | p.E180K | Q96BK5 | protein_coding | deleterious(0) | possibly_damaging(0.898) | TCGA-EK-A2R7-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
PINX1 | SNV | Missense_Mutation | c.853N>A | p.Glu285Lys | p.E285K | Q96BK5 | protein_coding | deleterious(0.05) | benign(0.006) | TCGA-FU-A2QG-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
PINX1 | SNV | Missense_Mutation | c.324G>T | p.Lys108Asn | p.K108N | Q96BK5 | protein_coding | deleterious(0.03) | possibly_damaging(0.635) | TCGA-A6-6141-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | 5-fu | SD | |
PINX1 | SNV | Missense_Mutation | c.551N>C | p.Lys184Thr | p.K184T | Q96BK5 | protein_coding | deleterious(0.03) | benign(0.426) | TCGA-AA-3851-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |